| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.9 |